Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pembrolizumab with chemoradiation for advanced cervical cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Linda R Duska | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03